BioFire seeks FDA clearance for blood culture ID system

04/17/2013 | GenomeWeb Daily News (free registration)

BioFire Diagnostics has filed a 510(k) clearance application with the FDA for a device that can screen positive blood cultures simultaneously for about 90% of the yeast microbes and gram-positive or gram-negative bacteria tied to bloodstream infections. The FilmArray Blood Culture Identification, or BCID, system could be released in the summer if cleared by the FDA.

View Full Article in:

GenomeWeb Daily News (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Behavioral Health Operations
Meridian Health Plan
Detroit, MI
Medical Director
PacificSource
Bend, OR
Clinical Appeals RN
MJHS
Brooklyn, NY
Director of Clinical Operations
Meridian Health Plan
Detroit, MI
Sr. Director, Regulatory Compliance Intelligence and Outreach
Johnson & Johnson
New Brunswick, NJ